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Abstract
The photophysics of hypericin have been studied in its complex with two different isoforms, A1-1 and P1-1, of
the protein glutathione S-transferase (GST). One molecule of hypericin binds to each of the two GST
subunits. Comparisons are made with our previous results for the hypericin/human serum albumin complex
(Photochem. Photobiol. 1999, 69, 633−645). Hypericin binds with high affinity to the GSTs: 0.65 μM for the
A1-1 isoform and 0.51 μM for the P1-1 isoform (Biochemistry 2004, 43, 12761−12769). The photophysics
and activity of hypericin are strongly modulated by the binding protein. Intramolecular hydrogen-atom
transfer is suppressed in both cases. Most importantly, while there is significant singlet oxygen generation
from hypericin bound to GST A1-1, binding to GST P1-1 suppresses singlet oxygen generation to almost
negligible levels. The data are rationalized in terms of a simple model in which the hypericin photophysics
depends entirely upon the decay of the triplet state by two competing processes, quenching by oxygen to yield
singlet oxygen and ionization, the latter of these two are proposed to be modulated by A1-1 and P1-1.
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The photophysics of hypericin have been studied in its complex with two different isoforms, A1-1 and P1-1,
of the protein glutathione S-transferase (GST). One molecule of hypericin binds to each of the two GST
subunits. Comparisons are made with our previous results for the hypericin/human serum albumin complex
(Photochem. Photobiol. 1999, 69, 633-645). Hypericin binds with high affinity to the GSTs: 0.65 íM for
the A1-1 isoform and 0.51 íM for the P1-1 isoform (Biochemistry 2004, 43, 12761-12769). The photophysics
and activity of hypericin are strongly modulated by the binding protein. Intramolecular hydrogen-atom transfer
is suppressed in both cases. Most importantly, while there is significant singlet oxygen generation from hypericin
bound to GST A1-1, binding to GST P1-1 suppresses singlet oxygen generation to almost negligible levels.
The data are rationalized in terms of a simple model in which the hypericin photophysics depends entirely
upon the decay of the triplet state by two competing processes, quenching by oxygen to yield singlet oxygen
and ionization, the latter of these two are proposed to be modulated by A1-1 and P1-1.
Introduction
Hypericin (Figure 1) is a major component of the botanical
dietary supplement, St. John’s Wort. It is a widely spread,
naturally occurring perylene quinone pigment that is of great
interest because of its broad spectrum of light-induced biological
activities.1-5 Here, we investigate the photophysics of hypericin
in complex with a biologically important protein to which it
binds with high affinity, glutathione S-transferase (GST).
GSTs (Figure 2) are biologically significant because they
catalyze the conjugation of reduced glutathione (GSH) to a
variety of electrophiles and thereby detoxify carcinogens,
pesticides, and reactive products generated under oxidative
stress. The conjugation of GSH with a foreign compound
generally results in the formation of a nontoxic product that
can be readily eliminated.6 In addition to their catalytic function,
GSTs also serve as nonenzymatic binding proteins, known as
ligandins, that interact with various lipophilic compounds that
include steroid and thyroid hormones. Finally, reactive oxygen
species can trigger apoptosis, programmed cell death, in cells.
The production of GSTs, by helping to protect the cell from
oxidative damage caused by reactive oxygen species, assists in
obviating the induction of apoptosis.6 Cytochrome P450,
especially the form CYP3A4 which predominates in hepatic
tissue, has functions similar to that of GST. It metabolizes
endogenous compounds and xenobiotics. It is believed to be
capable of binding multiple ligands, of the size of pyrene, and
we have shown that it can bind hypericin with high affinity.7
Human serum albumin (HSA) is the archetypal drug transport
protein, and we have studied hypericin bound to HSA exten-
sively in the past.8 Our hypericin/HSA results serve as a baseline
reference.
The biological activity of hypericin and its analogues depends
on light. Hypericin displays light-induced activity against several
types of viruses, including the human immunodeficiency virus
(HIV),9-11 as well as antiproliferative and cytotoxic effects on
tumor cells.12-15 Hypericin is also a potent antidepressant,16,17
exhibits light-dependent inhibition of protein kinase C (PKC),
which has been suggested to be a locus of its antiviral activity,18
and is reported to possess numerous other types of biological
behavior.19-21 Hypericin, like other anticancer drugs, also
induces apoptosis.22,23 Consequently, it is important to under-
stand the primary photophysical processes occurring after photon
absorption. Our work has produced several hypotheses concern-
ing the excited-state H-atom transfer in these molecules, namely,
that excited-state intramolecular hydrogen atom displacement
ultimately triggers the ejection of a proton. We have argued
that the antiviral activity of hypericin remains significant in the
absence of oxygen.24 The question then arises how hypericin
interacts with a cell and by what means its biological effects
* To whom correspondence should be addressed. E-mail: jwp@iastate.edu.
† Iowa State University.
‡ University of Washington.
Figure 1. Hypericin (7,14 normal form).
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are exerted. Photoactive molecules are traditionally depicted as
either interacting directly with a substrate (type I mechanisms)
or producing reactive oxygen species, especially singlet oxygen
(type II mechanisms) that exhibit toxicity. Clearly, hypericin
and its analogues produce parallel pathways, which work either
independently of the type I and type II mechanisms or in such
a way as to complement them. We wish to elucidate these
parallel pathways.
Owing to this light-induced biological activity, which is
diverse, widespread, and important, we have been studying the
early time photophysics of hypericin and its analogues.8,25-37
By means of H/D substitution, investigation of methoxy
analogues, and complementary studies using both transient
absorption and fluorescence upconversion spectroscopies, we
have argued that the major primary photophysical process in
hypericin in organic solvents is excited-state intramolecular
hydrogen-atom transfer.
After the intramolecular H-atom transfer, there is an inter-
molecular proton transfer to the solvent.38-40 This event is a
reversible process in vitro, as demonstrated by the conservation
of the sample optical density over the course of several cycles
of pH measurement. We have suggested that these photo-
generated protons may be important for understanding the light-
induced biological activity of hypericin.4 As we have discussed
elsewhere,8,41-43 this H-atom transfer is not observed when
hypericin is bound to HSA. Indeed, as we indicate below, this
transient is not observed when hypericin is bound to either A1-1
or P1-1, which leads us to speculate upon the relative roles of
singlet oxygen and photoinduced proton transfer in these
systems.
Materials and Methods
GST. The expression and purification of the GSTs, the
determination of their binding constants to hypericin, and the
quantification of their photoinduced oxidative damage via
hypericin have been thoroughly discussed by Lu and Atkins.7
Steady-State and Time-Resolved Measurements. Steady-
state absorbance spectra were obtained on Perkin-Elmer Lambda
18 double beam UV-vis spectrophotometer with 1-nm resolu-
tion. Steady-state fluorescence spectra were obtained on a Spex
Fluoromax with a 4-nm band-pass and corrected for lamp
spectral intensity and detector response. For both fluorescence
and absorption measurements, a 3-mm path length quartz cuvette
was used.
The apparatus for time-correlated single photon counting is
described elsewhere.26,27 Fluorescence decay kinetics were
recorded by exciting at 580 nm and collecting emission at >610
nm with a cutoff filter for a maximum of 10 000 counts at the
peak channel. The polarized fluorescence traces were used to
obtain fluorescence anisotropy decay parameters collected to a
maximum of 10 000 counts at the peak channel. Fits were
considered acceptable for ł2 e 1.2.
Flash Photolysis. Flash photolysis experiments were per-
formed with a system based on a 10-Hz Surelite I-10 (Con-
tinuum, Santa Clara, CA) Nd:YAG laser. The fundamental, 1064
nm, was frequency doubled, and the resulting radiation at 532
nm with a 100 mW of average power was used as the pump
source. A 75-W Xe lamp (Photon Technology International, NJ)
was used as a probe source. The UV from this Xe source was
filtered off with a benzene solution filter. Fluorescence and
scattered light were blocked by an 8-nm band-pass monochro-
mator at 520 nm before a 1P-28 photomultiplier. Transient
absorbance data were collected by a dual-channel 50-MHz
Picoscope 3000 (Pico Technology Ltd., U.K.).
Time-Resolved Pump-Probe Absorption Spectroscopy.
The instrument function of our time-correlated single photon
counting system has a full width at half maximum (fwhm) of
80 ps. To investigate a more rapid phenomenon, better time
resolution was required. This was provided by a homemade
regeneratively amplified Ti-sapphire system, providing 130-
fs pulses at 814 nm which was then frequency doubled and
used to perform pump-probe measurements.36,43,44 For the
pump-probe measurements, 407 nm was used as the pump
source and a white light continuum, as the probe source. The
probe wavelength was 600 nm.
Sample Preparation. A DMSO solution of hypericin was
used as the stock solution for sample preparation; the total
organic content of the final sample solution was <1% for both
hypericin/HSA and hypericin/A1-1 or hypericin/P1-1 in phos-
phate-EDTA buffer (pH 6.9). The hypericin/protein solutions
were incubated for about 4-7 h in the dark prior to steady-
state, time-resolved, and flash photolysis experiments. For
steady-state fluorescence measurements, the solutions were
Figure 2. GST isoforms: A1-1 (left), P1-1 (right). Although the two proteins are structurally very homologous, they share only 29% sequence
homology.7
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prepared with a stoichiometry of 10:1 protein-to-hypericin with
[hyp]  1.0  10-6 M. For time-resolved fluorescence studies,
[hyp]  5.0  10-6 M, varying amounts of protein concentra-
tions as indicated in Table 1 were employed. Flash photolysis
experiments were performed with [hyp]  5.0  10-5 M with
a 3:1 protein-to-hypericin ratio. For pump-probe experiments,
[hyp] was kept at 8.0  10-5 M and a 1:1 protein-to-hypericin
ratio was maintained. (The spectra were found to be similar in
the case of the 10:1 and 1:1 protein-to-hypericin ratios.)
Results and Discussion
Binding of Hypericin to GSTs and Singlet Oxygen
Generation. GST binds hypericin very tightly:7 A1-1 with KD
) 0.65 íM and P1-1 with KD ) 0.51 íM. Binding of hypericin
to GSTs also inhibits their catalytic activity.7 The submicromolar
affinity with which hypericin binds to GST is the first case of
high-affinity binding of hypericin to a biologically important
molecule that has been documented.
Our data suggest that one hypericin molecule binds to each
of the two subunits comprising GST (Table 1). Binding is
determined by monitoring the average fluorescence lifetime of
hypericin as a function of the GST/hypericin ratio. When GST/
hypericin <1/2, the average fluorescence lifetime decreases
significantly from a constant value of 3.3 ns. An even more
compelling indication of this binding ratio is that when it is
less than 1/2, the fluorescence anisotropy decay is no longer a
simple single exponential with a g20-ns depolarization time
but takes on a second much more rapid component indicative
of a chromophore loosely bound to the surface.8 For example,
when P1-1/hypericin is 1/3, r(t) ) 0.02 exp(-t/0.98 ns) + 0.27
exp(-t/19 ns).
An intriguing observation is that the photophysical properties
of hypericin can be altered upon binding to GSTs. In particular,
when hypericin binds to A1-1, light-induced oxidative damage
is produced, as evidenced by the mass spectrometry data
obtained after 30 min of optical irradiation. On the other hand,
no such oxidative damage is observed for P1-1. Figure 3
compares photosensitized oxidation by hypericin of HSA, A1-
1, and P1-1.7 While P1-1 is essentially impervious to oxidative
damage, both HSA and A1-1 are extremely susceptible.
Photophysics of Hypericin Bound to GSTs. As noted in
the Introduction, we have argued that one of the primary
processes deactivating the excited-state singlet of hypericin in
bulk organic solvent is intramolecular hydrogen-atom transfer.
The signature of this process is the rise time in the kinetics, as
indicated in Figure 4 for hypericin in DMSO. This process is
not, however, observed when hypericin is bound to HSA.8 We
interpreted this result in terms of hypericin binding to a
tryptophan residue in HSA that inhibited its H-atom transfer.
Given that intramolecular H-atom transfer is impeded in
hypericin/HSA and that light-induced protein oxidation of
hypericin/HSA is more similar to that of hypericin/A1-1 than
to that of hypericin/P1-1, it was our original expectation that
the photophysics of hypericin/A1-1 should more nearly resemble
that of hypericin/HSA than that of hypericin/P1-1. This expecta-
tion was not, however, borne out uniformly by subsequent
experiment: the singlet kinetics (Figure 4) and fluorescence
intensities (Figure 5) of hypericin/P1-1 more closely resemble
those of hypericin/HSA. On the other hand, the long-time
kinetics (Figure 6) indicate that the population of hypericin
radical ion in A1-1 is essentially identical to that generated in
complex with HSA and about a factor of 2 less than that
obtained in complex with P1-1.
We note that the data presented in Figure 4 are transient
absorption data, which detect both stimulated emission, induced
TABLE 1: Fluorescence Lifetimes of Hypericin Bound to
GSTsa
ô1 a1 ô2 a2 ô3 〈ô〉b
P1-1/hyp
10/1 140 0.24 1860 0.18 5400 3500
1/1 170 0.24 1550 0.14 5200 3480
1/1.7 160 0.31 1560 0.15 5200 3100
1/3 210 0.31 1890 0.15 5250 3180c
1/7 160 0.51 1460 0.14 5230 2120
1/10 130 0.72 1100 0.10 5200 1140
A1-1/hyp
10/1 300 0.28 2800 0.17 5900 3800
1/1 300 0.34 2000 0.14 5400 3200
1/1.7 280 0.43 2100 0.13 5650 2900
1/3 250 0.68 1200 0.15 5450 1250
1/10 150 0.86 820 0.12 4200 300
a All times are given in picoseconds. Fluorescence lifetimes are fit
to a sum of three exponentials. In all cases, [hyp]  5.0  10-6 M.
b The error in the average fluorescence lifetime is given by 〈ô〉 ) ∑iaiôi.
It is estimated to be accurate to ca. (15%. c This value is higher than
expected given the P1-1/hypericin ratio and the corresponding results
for A1-1/hypericin. Nevertheless, as we indicate in the text, under these
conditions, the fluorescence anisotropy decay departs from a single
exponential, indicating surface binding of the hypericin.
Figure 3. Protein oxidation from light-activated bound hypericin.
Details of the experiment are given by Lu and Atkins.7
Figure 4. Singlet kinetics of hypericin. The probe wavelength is 600
nm. Only hypericin in DMSO exhibits the 10-ps rise time attributed
to excited-state intramolecular H-atom transfer. Note that the hypericin/
P1-1 trace is nearly flat on the 40-ps time scale, more like that of
hypericin/HSA 8 than that of hypericin/A1-1.
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absorption, and ground-state bleaching. Consequently, there is
always the possibility that the interpretation of the observed
kinetics is complicated by several simultaneous phenomena. The
interpretation of the GST data is based upon our failure to see
a rise time for the 1:1 complex of hypericin/HSA in not only
transient absorption but also fluorescence upconversion experi-
ments,8 the latter of which only detect emission from the lowest
singlet state.
The long-time kinetics do not reflect the decay of the triplet,
T1. Indeed, we do not detect a transient triplet species for
hypericin bound to these proteins in our experiments. The
lifetime of hypericin triplet in an air-saturated solution at room
temperature is expected to be e1 ís, depending on the solvent
(see the caption to Figure 6).
No component of this duration is observed. We have
previously observed such long-lived species of hypericin and
its analogues in micelles.45 Jardon and co-workers have
discussed long-lived hypericin transients in terms of deproto-
nation of the hypericin triplet to form the anion,46,47 and we38
have shown that triplet hypericin is a proton donor. It thus seems
reasonable to attribute the long-lived transient to a deprotonated
species originating from the triplet, Hyp-, and in the following
discussion we refer to this species as a deprotonated or anionic
form of hypericin.
It may be argued that hypericin bound to P1-1 is not
accessible to oxygen and that this explains the absence of
oxidative damage in the complex. This is unlikely. First, the
structural homology of the two proteins (Figure 2) suggests that
hypericin binds similarly to both. Second, a more quantitative
indication is given by Stern-Volmer fluorescence quenching
experiments.7 Through the use of iodide as a quencher,
quenching constants of 4.3, 8.3, and 1.9 M-1 were obtained for
hypericin bound to A1-1, P1-1, and HSA, respectively.7 These
results indicate that hypericin bound to all three of these proteins
is accessible to fluorescence quenchers and that, in fact, it is
even slightly more accessible when bound to P1-1 than to the
other two proteins.
The unanticipated behavior of the singlet kinetics and the
fluorescence quantum yields originally proved quite puzzling
in light of the hypericin activity. They, however, can be
rationalized by considering the following points:
1. The intersystem crossing rate, kISC, must be five times
larger for hypericin/A1-1 than for hypericin/P1-1 in order to
explain the fluorescence quantum yield and the singlet decay
data, …˘
°1-1 ) 5…˘
P1-1 (Figures 4 and 5).
Figure 5. Absolute hypericin fluorescence intensity vs wavenumber.
The integrated intensities on the energy (wavenumber) scale provide
the fluorescence quantum yields (determined from these spectra), which
are given in parentheses in the figure. Again, note that the fluorescence
quantum yield of hypericin/P1-1 is more like that of hypericin/HSA
than that of hypericin/A1-1. The samples were excited at 550 nm.
Figure 6. Room-temperature, long-time kinetics of hypericin, reflecting
the behavior of the hypericin anion. For laser flash photolysis
experiments, samples were pumped at 532 nm and the transient was
probed after a monochromator set at 520 nm (see experimental details).
For all the samples [hyp]  5.0  10-5 M with 3:1 protein-to-hypericin
ratio. The solutions were prepared in phosphate-EDTA buffer (pH
6.9) for both GSTs and HSA. The traces are scaled to their relative
intensity, with the trace for hyp/P1-1 normalized to unit intensity at
time zero. These results were reproduced three times using a different
protein preparation for each experiment. For the long-time kinetics,
the intensity of the hypericin/A1-1 signal is essentially identical to that
of hypericin/HSA. In the context of earlier work by ourselves,38 Falk
and co-workers,48 and especially Jardon and co-workers,46,47 we attribute
the origin of these long-lived transients to the deprotonation of the
hypericin triplet. Jenks and co-workers49 have observed similar
transients arising from reduction and oxidation of triplet by electron
acceptors and donors. It is unlikely that the long-lived kinetics can be
attributed to the triplet. The time constant for triplet decay resulting
from oxygen quenching is estimated to be on the order of 5 ís assuming
a diffusion-controlled reaction and an oxygen concentration at atmo-
spheric pressure of 0.2 mM.50
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2. Note that the anion intensity of hypericin/A1-1 is about




3. The data in Figure 3 highlighting photosensitized oxidation
of protein imply that hypericin/A1-1 makes at least ten times




Consequently, we can rationalize hypericin/A1-1 being about
ten times more reactive than hypericin/P1-1.
4. We make the reasonable assumption that singlet oxygen
and hypericin anion are produced only by the triplet and that
their respective yields, …ion and …¢, are given by the standard
expressions
and
where we assume that k[O2] is the same for all the proteins
considered here. Taking the ratios of the respective yields
and
from which we conclude that
In other words, because the triplet state of hypericin is much
more susceptible to decay into the anion when it is bound to
P1-1 than to A1-1 or HSA, it generates considerably less singlet
oxygen when complexed to P1-1 than to the two latter proteins.
The origin of this difference can only be attributed to the amino
acids surrounding hypericin in the various proteins and their
effect on the excited-state photophysics of hypericin. An energy
level diagram summarizing these processes is given in Figure
7.
Conclusions
While the argument given above provides a pleasing ratio-
nalization of the kinetic and steady-state data and renders it
consistent with the light-induced biological reactivity of hy-
pericin in different protein environments, it is important to note
that the atomistic details of A1-1 and P1-1 giving rise to these
differences must still be resolved. This is a main goal of the
current work in progress.
An interesting consequence of this work is that it suggests
that insofar as the long-lived transient species depicted in Figure
6 can be attributed to the hypericin anion originating from the
triplet, Hyp-, even if there is no intramolecular H-atom transfer
in the singlet state for hypericin bound to HSA, A1-1, or P1-1,
the corresponding triplet state is still able to liberate a proton.
To date, the bulk of the photophysical studies of hypericin
has been carried out in homogeneous organic solution. Studying
the light-induced activity of hypericin in complex with biologi-
cally important proteins will contribute to an appreciation of
both its therapeutic utility as well as its possible toxicity.
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